Status:
COMPLETED
Evaluation of Sedation in COVID-19 ARDS
Lead Sponsor:
Goethe University
Conditions:
Prone Position
Severe Acute Respiratory Syndrome Coronavirus 2
Eligibility:
All Genders
18+ years
Brief Summary
This study focuses on the evaluation of various factors repeatedly discussed in relation to the impaired sedation of intubated ventilated COVID-19 patients. The sedation response of \>100 moderately t...
Eligibility Criteria
Inclusion
- moderate to severe COVID-19 ARDS
Exclusion
- None
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04667936
Start Date
March 1 2020
End Date
April 1 2021
Last Update
July 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany, 60590